Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Operating Leases (2019 - 2020)

Forte Biosciences (FBRX) has disclosed Operating Leases for 2 consecutive years, with $3.9 million as the latest value for Q1 2020.

  • On a quarterly basis, Operating Leases fell 59.07% to $3.9 million in Q1 2020 year-over-year; TTM through Mar 2020 was $3.9 million, a 59.07% decrease, with the full-year FY2019 number at $4.0 million, changed N/A from a year prior.
  • Operating Leases was $3.9 million for Q1 2020 at Forte Biosciences, down from $4.0 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $9.6 million in Q1 2019 to a low of $3.9 million in Q1 2020.